In the 1970s, Pittsburgh was home to the largest comprehensive cancer center in the nation.

More than two dozen M.D.s and Ph.D.s, recruited from all over the country, worked to research and treat the disease at the Clinical Oncology Lab at Allegheny General Hospital. And despite having neither lofty degree, Milton Dalbow was at the center of it.

“He was way beyond what you ever thought you would see in a guy who didn’t have an advanced degree,” said Larry Schenken, former director of the Clinical Oncology Lab. “He was a really great guy scientifically and personally.”

Mr. Dalbow of Springdale Borough rose to chief of clinical operations at the oncology lab. He was an author of 30 papers published in scientific journals, including Nature and the New England Journal of Medicine, and held several patents for cancer treatment and detection.

Advertise with us

He died Wednesday of prostate cancer. He was 88.

Born in Springdale, Mr. Dalbow joined the Army in 1944 after graduating from high school. He was in the Ardennes area of France during the Battle of the Bulge in 1944, an experience that left him “so cold he could never get warm enough,” said his daughter, Laura Combemale of Marshall. “He used to wear jackets in the summertime.”

While he was in the Army, he got letters from a young woman named Dorothy Fetchko, a high school classmate he only vaguely remembered who had been assigned to write him through a local soldier support effort.

When he returned from the Army and enrolled at the University of Pittsburgh, he happened to run into Miss Fetchko on a bus.

They began meeting up at the Cathedral of Learning and married in 1950, the same year that Mr. Dalbow joined the Air Force, serving as a captain during the Korean War. He graduated from Pitt in 1949 with a degree in chemistry and earned a master’s degree in biology in 1959.

Advertise with us

In 1970, he started working in radiation oncology at Allegheny General, rising to chief of laboratory operations in 1982. Eighty hour workweeks weren’t unusual, said his daughter, as Mr. Dalbow was incredibly devoted to his patients and his research.

“He had an understanding of the disease that you could only get by putting many, many hours into researching it,” said his daughter. “He spent a lot of time getting to know his patients.”

Mr. Dalbow’s research focused on immunology and tumor markers. He did very early work on the CEA general tumor marker that is still being used today, said Mr. Schenken. In the 1970s, Mr. Dalbow was also doing research on AIDS patients, noting characteristics of their immune systems even before the disease had been formally identified.

He was driven to cancer research in part because his father had died from stomach cancer at 59. “For him it was so important to understand the horrible disease that had taken my grandfather,” said his daughter. “He made small steps that have led to where we are today.”

He retired from Allegheny General in 1989, though he continued consulting into the 1990s.

Advertise with us

In addition to his daughter, he is survived by sons Milton Randall Dalbow of Beaufort, S.C., Michael Dalbow of Edwards, Colo., Mark Dalbow of Irwin; and eight grandchildren.

A private memorial service is planned for later this month.